Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
EyePoint Pharmaceuticals Inc banner

EyePoint Pharmaceuticals Inc
F:PV3B

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
F:PV3B
Watchlist
Price: 11.4 EUR 4.59% Market Closed
Market Cap: €593.8m
Write Note Create Alert Ask AI

Wall St Price Targets

PV3B Price Targets Summary
EyePoint Pharmaceuticals Inc

Wall Street analysts forecast PV3B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PV3B is 33.29 EUR with a low forecast of 15.96 EUR and a high forecast of 56.41 EUR.

PV3B Lowest Forecast
Wall Street Target
€15.96
40% Upside
PV3B Average Forecast
Wall Street Target
€33.29
192% Upside
PV3B Highest Forecast
Wall Street Target
€56.41
395% Upside
Lowest Forecast
Price Target
15.96 EUR
40% Upside
Average Forecast
Price Target
33.29 EUR
192% Upside
Highest Forecast
Price Target
56.41 EUR
395% Upside
EyePoint Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
17% / Year
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 63%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Gross Profit over the next 8 years is 62%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Continue PV3B Research

Summary
PV3B intrinsic value, competitors valuation, and company profile.
DCF Valuation
PV3B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PV3B stock valuation using valuation multiples.
Wall St Estimates
PV3B price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PV3B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other EyePoint Pharmaceuticals Inc listings:
NASDAQ • USD
EYPT
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PV3B's stock price target?
Price Target
33.29 EUR

According to Wall Street analysts, the average 1-year price target for PV3B is 33.29 EUR with a low forecast of 15.96 EUR and a high forecast of 56.41 EUR.

What is the Revenue forecast for EyePoint Pharmaceuticals Inc?
Projected CAGR
63%

Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 63%.

What is the Gross Profit forecast for EyePoint Pharmaceuticals Inc?
Projected CAGR
62%

The compound annual growth rate for Gross Profit over the next 8 years is 62%.

Back to Top
ALPHA SPREAD
Follow us
Join 354,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett